Browsing by Author Mamo, David

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 13 to 32 of 69 < previous   next >
Issue DateTitleAuthor(s)
2009D2 receptor blockade by risperidone correlates with attention deficits in late-life schizophreniaUchida, Hiroyuki; Rajji, Tarek K.; Mulsant, Benoit H.; Kapur, Shitij; Pollock, Bruce G.; Graff-Guerrero, Ariel; Menon, Mahesh; Mamo, David
2008D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography : an open-label study in patients with schizophreniaMamo, David; Kapur, Shitij; Keshavan, Matcheri; Laruelle, Marc; Taylor, Cindy C.; Kothare, Prajakti A.; Barsoum, Penny; McDonnell, David
2012Defining treatment-resistant schizophrenia and response to antipsychotics : a review and recommendationSuzuki, Takefumi; Remington, Gary; Mulsant, Benoit H.; Uchida, Hiroyuki; Rajji, Tarek K.; Graff-Guerrero, Ariel; Mimura, Masaru; Mamo, David
2012Delineating the functional neuroanatomy of illness denial or anosognosia in schizophreniaGerretsen, Philip; Graff-Guerrero, Ariel; Mamo, David; Pollock, Bruce G.; Menon, Mahesh
2007Differential effects of aripiprazole on D 2, 5-HT 2, and 5-HT 1A receptor occupancy in patients with schizophrenia : a triple tracer PET studyMamo, David; Graff-Guerrero, Ariel; Mizrahi, Romina; Shammi, Chekkera M.; Romeyer, Franvoise; Kapur, Shitij
2010Differentiating the cognitive profile of schizophrenia from that of Alzheimer disease and depression in late lifeTing, Christina; Rajji, Tarek K.; Ismail, Zahinoor; Tang-Wai, David F.; Apanasiewicz, Nina; Miranda, Dielle; Mamo, David; Mulsant, Benoit H.
2015Dopamine D 2/3 receptor availability in the striatum of antipsychotic-free older patients with schizophrenia : a [11 C]-raclopride PET studyNakajima, Shinichiro; Caravaggio, Fernando; Mamo, David; Mulsant, Benoit H.; Chung, Jun Ku; Plitman, Eric; Iwata, Yusuke; Gerretsen, Philip; Uchida, Hiroyuki; Suzuki, Takefumi; Mar, Wanna; Wilson, Alan A.; Houle, Sylvain; Graff-Guerrero, Ariel
2015Dopamine D 2/3 receptor occupancy following dose reduction is predictable with minimal plasma antipsychotic concentrations : an open-label clinical trialNakajima, Shinichiro; Uchida, Hiroyuki; Bies, Robert R.; Caravaggio, Fernando; Suzuki, Takefumi; Plitman, Eric; Mar, Wanna; Gerretsen, Philip; Pollock, Bruce G.; Mulsant, Benoit H.; Mamo, David; Graff-Guerrero, Ariel
2012Dopamine D2 receptor occupancy and cognition in schizophrenia : analysis of the CATIE dataSakurai, Hitoshi; Bies, Robert R.; Stroup, Scott T.; Keefe, Richard S. E.; Rajji, Tarek K.; Suzuki, Takefumi; Mamo, David; Pollock, Bruce G.; Watanabe, Koichiro; Mimura, Masaru; Uchida, Hiroyuki
2012Dopamine D2 receptor occupancy with risperidone or olanzapine during maintenance treatment of schizophrenia : a cross-sectional studyMizuno, Yuya; Bies, Robert R.; Remington, Gary; Mamo, David; Suzuki, Takefumi; Pollock, Bruce G.; Tsuboi, Takashi; Watanabe, Koichiro; Mimura, Masaru; Uchida, Hiroyuki
2013Dopamine D2/3 occupancy of ziprasidone across a day : a within-subject PET studySuzuki, Takefumi; Graff-Guerrero, Ariel; Uchida, Hiroyuki; Remington, Gary; Caravaggio, Fernando; Borlido, Carol; Pollock, Bruce G.; Mulsant, Benoit H.; Deluca, Vincenzo; Ismail, Zahinoor; Mamo, David
2009Dosing of antipsychotics in schizophrenia across the life-spectrumUchida, Hiroyuki; Mamo, David
2004Effect of acute antipsychotic administration on dopamine synthesis in rodents and human subjects using 6‐[18F]‐L‐m‐tyrosineMamo, David; Remington, Gary; Nobrega, Jose N.; Hussey, Doug; Chirakal, Raman; Wilson, Alan A.; Baker, Glen B.; Houle, Sylvain; Kapur, Shitij
2002The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disordersMamo, David; Sweet, Robert A.; Roy Chengappa, Kadiamada N.; Reddy, Ravinder R.; Jeste, Dilip V.
2011Effects of aging on 5‐HT2AR binding : a HRRT PET study with and without partial volume correctionsUchida, Hiroyuki; Chow, Tiffany W.; Mamo, David; Kapur, Shitij; Mulsant, Benoit H.; Houle, Sylvain; Pollock, Bruce G.; Graff-Guerrero, Ariel
2004EMD 281014, a specific and potent 5HT2 antagonist in humans : a dose-finding PET studyMamo, David; Sedman, Ewen; Tillner, Joachim; Sellers, Edward M.; Romach, Myroslava K.; Kapur, Shitij
2013Estimated dopamine D2 receptor occupancy and remission in schizophrenia : analysis of the CATIE dataMoriguchi, Sho; Bies, Robert R.; Remington, Gary; Suzuki, Takefumi; Mamo, David; Watanabe, Koichiro; Mimura, Masaru; Pollock, Bruce G.; Uchida, Hiroyuki
2014Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [11C]-(+)-PHNOCaravaggio, Fernando; Nakajima, Shinichiro; Borlido, Carol; Remington, Gary; Gerretsen, Philip; Wilson, Alan; Houle, Sylvain; Menon, Mahesh; Mamo, David; Graff-Guerrero, Ariel
2016Estimating the effect of endogenous dopamine on baseline [11C]‐(+)‐PHNO binding in the human brainCaravaggio, Fernando; Kegeles, Lawrence S.; Wilson, Alan A.; Remington, Gary; Borlido, Carol; Mamo, David; Graff-Guerrero, Ariel
2011Exploring the neural correlates of delusions of referenceMenon, Mahesh; Schmitz, Taylor W.; Anderson, Adam K.; Graff, Ariel; Korostil, Michele; Mamo, David; Gerretsen, Philip; Addington, Jean; Remington, Gary; Kapur, Shitij